Products
Platform
Research
Market
Learn
Partner
Support
IPO

G

Gennex Laboratories Share Price

12.97
-0.17 (-1.29%)
GENNEX • 19 Jan, 2026 | 03:29 PM

1Y Annualised Return

-16.25%

3Y Annualised Return

29.31%

5Y Annualised Return

19.68%

10Y Annualised Return

4.88%

The current prices are delayed, login or Open Demat Account for live prices.

Gennex Laboratories Stock Performance

1W Return-8.79
1Y Return-18.02
Today's Low12.95
Prev. Close13.14
Mkt Cap (Cr.)315.10
1M Return3.76
3Y Return112.62
52-Week High17.25
Open13.06
PE Ratio21.62
6M Return-5.19
Today's High13.47
52-Week Low10.84
Face Value1

Gennex Laboratories Company background

Founded in: 1990
Managing director: Arihant Baid
Gennex Laboratories Limited, formerly known as Prudential Pharmaceuticals Limited was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007.The Company is in the business of Manufacturing of Bulk Drugs, Intermediates and Biotech Products. The Company has over the years added more capacity and infrastructure by way of an additional production block and equipment to the plant to handle more products and tonnages. The Company is having a professionally managed team at every stage of its operations.Apart from these, Gennex is among the leading Vertically Integrated pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal. The company thrives on the strength of its exports to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others. The Companys factory is situated at Andhra Pradesh, India. The company has a professionally managed team at every stage of its operations.During the year 20052006, the company implemented GMP (Good Manufacturing Practices). In 200607, it installed Separate Air Handling System in final drug isolation area and also in drying and packing area. Also, it implemented the CGMP in manufacturing area as per ICH WHO Guidelines. In 20072008, it diversified into the business of Biotech product. The Company acquired 51% shareholding in Deccan Remedies Limited and thus became the subsidiary of the Company in 2023.

Gennex Laboratories Financial Highlights


For the full year FY2025–2026, revenue reached ₹148.33 crore and profit touched at ₹18.12 crore.

Gennex Laboratories Share Price Today


As of 19 Jan 2026, Gennex Laboratories share price is ₹13. The stock opened at ₹13.1 and had closed at ₹13.1 the previous day. During today’s trading session, Gennex Laboratories share price moved between ₹12.95 and ₹13.47, with an average price for the day of ₹13.21. Over the last 52 weeks, the stock has recorded a low of ₹10.84 and a high of ₹17.25. In terms of performance, Gennex Laboratories share price has declined by 5.2% over the past six months and has declined by 16.25% over the last year.
Read More
Gennex Laboratories SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 5 years with a gain of 0 (+0.00%)
View details of Market Depth

Gennex Laboratories Fundamental

Market Cap (in crs)

315.10

Face Value

1

Turnover (in lacs)

39.25

Key Metrics

Qtr Change %
-7.6
Dividend yield 1yr %
0

Gennex Laboratories Key Financials

View more
Loading chart...
Gennex Laboratories Quarterly Revenue
Gennex Laboratories Yearly Revenue
Gennex Laboratories Quarterly Net Profit/Loss
Gennex Laboratories Yearly Net Profit/Loss

Gennex Laboratories Shareholding Pattern

Promoter
23.6%
Public
76.4%

Gennex Laboratories Technical Analysis

Moving Averages Analysis
12.97
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
Day EMA5
13.40
Day EMA10
13.50
Day EMA12
13.60
Day EMA20
13.60
Day EMA26
13.60
Day EMA50
13.60
Day EMA100
13.50
Day EMA200
13.80
Delivery & Volume
Loading chart...

Day

87.00%

Week

83.80%

Month

77.30%

Delivery & Volume

13.13
Pivot
Resistance
First Resistance
13.31
Second Resistance
13.65
Third Resistance
13.83
Support
First Support
12.79
Second support
12.61
Third Support
12.27
Relative Strength Index
42.25
Money Flow Index
52.74
MACD
-0.04
MACD Signal
0.03
Average True Range
0.73
Average Directional Index
15.50
Rate of Change (21)
2.21
Rate of Change (125)
-6.56
Compare

Gennex Laboratories Latest News

12 JAN 2026 | Monday
16 DEC 2025 | Tuesday
17 NOV 2025 | Monday

Please be aware that Gennex Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account